Benign Prostatic Hyperplasia

Use of 5-ARIs May Decrease Bladder Cancer Risk

Publish Date May 15, 2022

A study examined bladder cancer risk and mortality among nearly 100,000 men from Ontario, Canada, who received 5-alpha reductase inhibitors.

Water Vapor Therapy for BPH Safe, Effective in Large Real-World Study

Publish Date May 14, 2022

Rezūm therapy significantly improved symptoms, urinary flow, and quality of life in men across a wide range of prostate sizes, data show.

Rise in Prostatic Urethral Lift Use for BPH Reported

Publish Date May 13, 2022

The procedure is now performed in one-third of all surgeries for benign prostatic hyperplasia, a study found.

5-ARIs Do Not Increase Prostate Cancer Mortality

Publish Date May 13, 2022

Data on whether 5-ARIs increase the risk of prostate cancer-specific mortality have been mixed.

BPH Surgical Outcomes Worse After PAE vs TURP, PUL

Publish Date May 13, 2022

Prostatic artery embolization is a minimally invasive surgical technique that involves selective cannulation of the prostatic arteries.

Male Lower Urinary Tract Symptoms Up Death Risk

Publish Date May 6, 2022

Bothersome or not, lower urinary tract symptoms increase mortality risk in men.

Larger Prostates Up Odds of Converting From HoLEP to Open Prostatectomy

Publish Date April 5, 2022

The likelihood of conversion from HoLEP to an open procedure to treat benign prostatic hyperplasia increases along with prostate size.

Entadfi Approved for Benign Prostatic Hyperplasia

Publish Date January 5, 2022

Entadfi is a fixed-dose combination of finasteride, a 5α-reductase inhibitor, and tadalafil, a phosphodiesterase 5 (PDE5) inhibitor.

Investigators: Consider 5-ARI Use When Deciding on Prostate Biopsy

Publish Date September 12, 2021

At prostate cancer diagnosis, clinical T stage was significantly higher among 5-ARI users compared with nonusers.

Fewer Complications After Laser Enucleation of the Prostate

Publish Date September 10, 2021

Laser enucleation of the prostate accounts for less than 5% of all BPH procedures performed in the US.